FDA inspection
NewYork-Presbyterian Columbia Irving Medical Center: FDA inspection ending Nov 28, 2023
FDA inspection 1223803 · Voluntary Action Indicated (VAI) · New York, NY
Key facts
| Inspection ID | 1223803 |
|---|---|
| Firm | NewYork-Presbyterian Columbia Irving Medical Center |
| FEI number | 2474233 |
| Address | 622 W 168th St |
| City | New York |
| State | NY |
| ZIP | 10032 |
| Country | United States |
| Fiscal year | 2024 |
| Inspection end date | Nov 28, 2023 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data